Experts were comforted that companies are following safety precautions. They pointed out that pauses in vaccine trials are common, but pauses in treatment trials like Eli Lilly’s are rare.
Published: October 14, 2020 at 06:36PM
from NYT Health https://ift.tt/33Xwjb6